A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ODEVIXIBAT (A4250) IN CHILDREN WITH BILIARY ATRESIA WHO HAVE UNDERGONE A KASAI HEPATOPORTOENTEROSTOMY

Registry ID

A4250-011

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

IPSEN PHARMA

Start date

2023-10-26

Last update

2020-05-26

Conditions

• BILIARY ATRESIA

Related clinical trials

• AN OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM EFFICACY AND SAFETY OF ODEVIXIBAT (A4250) IN CHILDREN WITH BILIARY ATRESIA (BOLD-EXT).

View on source registry